Alzheimer's Combo Treatment OKd by FDA Newsmax Health The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis and Adamas Pharmaceuticals. Adamas shares were up nearly 17 percent at $17.10 in premarket trading. The drug, Namzaric is ... |
Day: December 24, 2014
UPDATE 1-Actavis, Adamas win FDA approval for Alzheimer’s drug – Reuters
Pharmaceutical Business Review | UPDATE 1-Actavis, Adamas win FDA approval for Alzheimer's drug Reuters (Adds details, background, share). Dec 24 (Reuters) - The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis Plc and Adamas Pharmaceuticals Inc. Adamas shares were up nearly 17 ... Actavis, Adamas Pharma Win FDA Approval For Alzheimer's Drug Namzaric Actavis Alzheimers Drug Approved; Bystolic Gets CRL Actavis, Adamas win FDA approval for Alzheimer's drug |
Actavis, Adamas win FDA approval for Alzheimer’s drug – Reuters
Pharmaceutical Business Review | Actavis, Adamas win FDA approval for Alzheimer's drug Reuters (Reuters) - The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis Plc and Adamas Pharmaceuticals Inc. Adamas shares were up nearly 17 percent at $17.10 in premarket trading. Actavis, Adamas Pharma Win FDA Approval For Alzheimer's Drug Namzaric |